Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025;26(3):149-152.
doi: 10.2174/0113892002411444250714224249.

Advancing Liposomal Drug Delivery through Physiologically-Based Pharmacokinetic Modeling

Affiliations
Editorial

Advancing Liposomal Drug Delivery through Physiologically-Based Pharmacokinetic Modeling

Hellen Flavia Goncalves Braz et al. Curr Drug Metab. 2025.
No abstract available

PubMed Disclaimer

References

    1. van der Koog L.; Gandek T.B.; Nagelkerke A.; Liposomes and extracellular vesicles as drug delivery systems: A comparison of composition, pharmacokinetics, and functionalization. Adv Healthc Mater 2022,11(5),2100639 - DOI - PubMed
    1. He H.; Yuan D.; Wu Y.; Cao Y.; Pharmacokinetics and pharmacodynamics modeling and simulation systems to support the development and regulation of liposomal drugs. Pharmaceutics 2019,11(3),110 - DOI - PubMed
    1. Ozbek O.; Genc D.E.O.; Ulgen K.; Advances in physiologically based pharmacokinetic (PBPK) modeling of nanomaterials. ACS Pharmacol Transl Sci 2024,7(8),2251-2279 - DOI - PubMed
    1. Minnema J.; Borgos S.E.F.; Liptrott N.; Vandebriel R.; Delmaar C.; Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances. Drug Deliv Transl Res 2022,12(9),2132-2144 - DOI - PubMed
    1. Lin W.; Chen Y.; Unadkat J.D.; Zhang X.; Wu D.; Heimbach T.; Applications, challenges, and outlook for pbpk modeling and simulation: A regulatory, industrial and academic perspective. Pharm Res 2022,39(8),1701-1731 - DOI - PubMed

Publication types